Jefferies Reiterates Buy on Medidata (MDS) as Deals Roll In

November 1, 2012 2:09 PM EDT
Get Alerts MDSO Hot Sheet
Price: $92.22 --0%

Rating Summary:
    5 Buy, 11 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies reiterated a Buy on Medidata Solutions (NASDAQ: MDSO) and raised its price target to $48.50 (from $41.00). Medidata Solutions is global provider of hosted clinical development solutions designed to improve the efficiency of the clinical development process.

Commenting on the company's recent earning release, analyst David Windley said "Investors looked past the EPS miss and lower 2012/2013 EPS outlook, eventually focusing on the numerous enterprise wins and positive implications for revenue growth."

In the last few months, Medidata signed enterprise deals with Sanofi (NYSE: SAN), Otsuka, Baxter (NYSE: BAX) and others. These wins come on top of a $100 million deal announced in Q2.

"The pace has been impressive, and the 4Q pipeline appears to be full as well. However, closing these types of deals consistently each quarter is a tough standard,” said Windley.

For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.

Shares of Medidata Solutions closed at $42.02 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co